Literature DB >> 24376213

Potocki-Shaffer deletion encompassing ALX4 in a patient with frontonasal dysplasia phenotype.

Alessandra Ferrarini1, Muriel Gaillard, Frederic Guerry, Gianpaolo Ramelli, Fodstad Heidi, Caroline Verley Keddache, Ilse Wieland, Jacques S Beckmann, Sébastien Jaquemont, Danielle Martinet.   

Abstract

Frontonasal dysplasia (FND) is a genetically heterogeneous malformation spectrum with marked hypertelorism, broad nasal tip and bifid nose. Only a small number of genes have been associated with FND phenotypes until now, the first gene being EFNB1, related to craniofrontonasal syndrome (CFNS) with craniosynostosis in addition, and more recently the aristaless-like homeobox genes ALX3, ALX4, and ALX1, which have been related with distinct phenotypes named FND1, FND2, and FND3 respectively. We here report on a female patient presenting with severe FND features along with partial alopecia, hypogonadism and intellectual disability. While molecular investigations did not reveal mutations in any of the known genes, ALX4, ALX3, ALX1 and EFNB1, comparative genomic hybridization (array CGH) techniques showed a large heterozygous de novo deletion at 11p11.12p12, encompassing the ALX4 gene. Deletions in this region have been described in patients with Potocki-Shaffer syndrome (PSS), characterized by biparietal foramina, multiple exostoses, and intellectual disability. Although the patient reported herein manifests some overlapping features of FND and PPS, it is likely that the observed phenotype maybe due to a second unidentified mutation in the ALX4 gene. The phenotype will be discussed in view of the deleted region encompassing the ALX4 gene.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  11p11p12; ALX4; Potocki-Shaffer syndrome; fronto-nasal dysplasia

Mesh:

Substances:

Year:  2013        PMID: 24376213     DOI: 10.1002/ajmg.a.36140

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  De novo truncating variants in PHF21A cause intellectual disability and craniofacial anomalies.

Authors:  Kohei Hamanaka; Yuji Sugawara; Takeyoshi Shimoji; Tone Irene Nordtveit; Mitsuhiro Kato; Mitsuko Nakashima; Hirotomo Saitsu; Toshimitsu Suzuki; Kazuhiro Yamakawa; Ingvild Aukrust; Gunnar Houge; Satomi Mitsuhashi; Atsushi Takata; Kazuhiro Iwama; Ahmed Alkanaq; Atsushi Fujita; Eri Imagawa; Takeshi Mizuguchi; Noriko Miyake; Satoko Miyatake; Naomichi Matsumoto
Journal:  Eur J Hum Genet       Date:  2018-11-28       Impact factor: 4.246

2.  Association of Novel ALX4 Gene Polymorphisms with Antidepressant Treatment Response: Findings from the CO-MED Trial.

Authors:  Bharathi S Gadad; Prithvi Raj; Manish K Jha; Thomas Carmody; Igor Dozmorov; Taryn L Mayes; Edward K Wakeland; Madhukar H Trivedi
Journal:  Mol Neuropsychiatry       Date:  2018-05-03

3.  HOXB13 and ALX4 induce SLUG expression for the promotion of EMT and cell invasion in ovarian cancer cells.

Authors:  Hong Yuan; Hiroaki Kajiyama; Satoko Ito; Dan Chen; Kiyosumi Shibata; Michinari Hamaguchi; Fumitaka Kikkawa; Takeshi Senga
Journal:  Oncotarget       Date:  2015-05-30

4.  A 20 bp Duplication in Exon 2 of the Aristaless-Like Homeobox 4 Gene (ALX4) Is the Candidate Causative Mutation for Tibial Hemimelia Syndrome in Galloway Cattle.

Authors:  Bertram Brenig; Ekkehard Schütz; Michael Hardt; Petra Scheuermann; Markus Freick
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

5.  Differential expression of aristaless-like homeobox 4: a potential marker for gastric adenocarcinoma.

Authors:  Fariba Ghasemvand; Navid Nezafat; Saeed Hesami Tackallou; Daruosh Momenzadeh; Saeid Rahmanzadeh
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016

6.  11p11.12p12 duplication in a family with intellectual disability and craniofacial anomalies.

Authors:  Xuejiao Chen; Huihui Xu; Weiwu Shi; Feng Wang; Fenfen Xu; Yang Zhang; Jun Gan; Xiong Tian; Baojun Chen; Meizhen Dai
Journal:  BMC Med Genomics       Date:  2021-04-09       Impact factor: 3.063

7.  Genetic prediction of male pattern baldness.

Authors:  Saskia P Hagenaars; W David Hill; Sarah E Harris; Stuart J Ritchie; Gail Davies; David C Liewald; Catharine R Gale; David J Porteous; Ian J Deary; Riccardo E Marioni
Journal:  PLoS Genet       Date:  2017-02-14       Impact factor: 5.917

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.